Effects of choline on health across the life course: A systematic review

Nutrition Reviews

Volumn 73, Issue 8, 2015, Pages 500-522

  Leermakers, Elisabeth T M ^a   Moreira, Eduardo M ^a   Kiefte de Jong, Jessica C ^a   Darweesh, Sirwan K L ^a   Visser, Thirsa ^a   Voortman, Trudy ^a   Bautista, Paula K ^a   Chowdhury, Rajiv ^b   Gorman, Donal ^b   Bramer, Wichor M ^a   Felix, Janine F ^a   Franco, Oscar H ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Body composition; Cardiovascular health; Choline; Metabolic health; Neurology

Indexed keywords

CHOLINE; LIPID; VERY LOW DENSITY LIPOPROTEIN;

ARTICLE; BODY COMPOSITION; CARDIOMETABOLIC RISK; CASE CONTROL STUDY; COGNITION; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; DIET SUPPLEMENTATION; DIETARY INTAKE; HEALTH STATUS; HUMAN; LIPID BLOOD LEVEL; NERVOUS SYSTEM; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; RESPIRATORY SYSTEM; SYSTEMATIC REVIEW; BLOOD; DRUG EFFECTS; PHYSIOLOGY;

BODY COMPOSITION; CHOLINE; DIETARY SUPPLEMENTS; HEALTH STATUS; HUMANS; LIPIDS;

EID: 84945124963     PISSN: 00296643     EISSN: 17534887     Source Type: Journal    
DOI: 10.1093/nutrit/nuv010     Document Type: Article

References (83)

1. Zeisel SH. Choline: an essential nutrient for humans. Nutrition. 2000;16:669-671.
2. Ueland PM. Choline and betaine in health and disease. J Inherit Metab Dis. 2011; 34:3-15.
3. Olthof MR, van Vliet T, Verhoef P, et al. Effect of homocysteine-lowering nutrients on blood lipids: results from four randomised, placebo-controlled studies in healthy humans. PloS Med. 2005;2:446-456.
4. Dalmeijer GW, Olthof MR, Verhoef P, et al. Prospective study on dietary intakes of folate, betaine, and choline and cardiovascular disease risk in women. Eur J Clin Nutr. 2008;62:386-394.
5. Corbin KD, Zeisel SH. Choline metabolism provides novel insights into nonalcoholic fatty liver disease and its progression. Curr Opin Gastroenterol. 2012;28:159- 165.
6. Al Rajabi A, Castro GS, da Silva RP, et al. Choline supplementation protects against liver damage by normalizing cholesterol metabolism in Pemt/Ldlr knockout mice fed a high-fat diet. J Nutr. 2014;144:252-257.
7. Guerrerio AL, Colvin RM, Schwartz AK, et al. Choline intake in a large cohort of patients with nonalcoholic fatty liver disease. Am J Clin Nutr. 2012;95:892-900.
8. Zeisel SH. Nutrition in pregnancy: the argument for including a source of choline. Int J Womens Health. 2013;5:193-199.
9. McCann JC, Hudes M, Ames BN. An overview of evidence for a causal relationship between dietary availability of choline during development and cognitive function in offspring. Neurosci Biobehav Rev. 2006;30:696-712.
10. Conant R, Schauss AG. Therapeutic applications of citicoline for stroke and cognitive dysfunction in the elderly: a review of the literature. Altern Med Rev. 2004;9: 17-31.
11. Fioravanti M, Yanagi M. Cytidinediphosphocholine (CDP-choline) for cognitive and behavioural disturbances associated with chronic cerebral disorders in the elderly. Cochrane Database Syst Rev. 2005(2):CD000269. doi:10.1002/ 14651858.CD000269.pub3.
12. Carter P, Gray LJ, Troughton J, et al. Fruit and vegetable intake and incidence of type 2 diabetes mellitus: systematic review and meta-analysis. BMJ. 2010;341: c4229. doi:10.1136/bmj.c4229.
13. National Collaborating Centre for Methods and Tools. Quality assessment tool for quantitative studies. Hamilton, Ontario: McMaster University; 2008. Available at: http://www.nccmt.ca/registry/view/eng/14.html. Accessed April 13, 2010.
14. Carmichael SL, Yang W, Shaw GM. Periconceptional nutrient intakes and risks of neural tube defects in California. Birth Defects Res Part A Clin Mol Teratol. 2010; 88:670-678.
15. Shaw GM, Carmichael SL, Yang W, et al. Periconceptional dietary intake of choline and betaine and neural tube defects in offspring. Am J Epidemiol. 2004;160: 102-109.
16. Mills JL, Fan R, Brody LC, et al. Maternal choline concentrations during pregnancy and choline-related genetic variants as risk factors for neural tube defects. Am J Clin Nutr. 2014;100:1069-1074.
17. Cheatham CL, Goldman BD, Fischer LM, et al. Phosphatidylcholine supplementation in pregnant women consuming moderate-choline diets does not enhance infant cognitive function: a randomized, double-blind, placebo-controlled trial. Am J Clin Nutr. 2012;96:1465-1472.
18. Villamor E, Rifas-Shiman SL, Gillman MW, et al. Maternal intake of methyl-donor nutrients and child cognition at 3 years of age. Paediatr Perinat Epidemiol. 2012; 26:328-335.
19. Boeke CE, Gillman MW, Hughes MD, et al. Choline intake during pregnancy and child cognition at age 7 years. Am J Epidemiol. 2013;177:1338-1347.
20. Signore C, Ueland PM, Troendle J, et al. Choline concentrations in human maternal and cord blood and intelligence at 5 y of age. Am J Clin Nutr. 2008;87: 896-902.
21. Wu BTF, Dyer RA, King DJ, et al. Early second trimester maternal plasma choline and betaine are related to measures of early cognitive development in term infants. PLoS One. 2012;7:43348. doi:10.1371/journal.pone.0043448.
22. Strain JJ, McSorley EM, van Wijngaarden E, et al. Choline status and neurodevelopmental outcomes at 5 years of age in the Seychelles Child Development Nutrition Study. Br J Nutr. 2013;110:330-336.
23. Nurk E, Refsum H, Bjelland I, et al. Plasma free choline, betaine and cognitive performance: the Hordaland Health Study. Br J Nutr. 2012:109:511-519.
24. Poly C, Massaro JM, Seshadri S, et al. The relation of dietary choline to cognitive performance and white-matter hyperintensity in the Framingham Offspring Cohort. Am J Clin Nutr. 2011;94:1584-1591.
25. Sitaram N, Weingartner H, Caine ED, et al. Choline: selective enhancement of serial learning and encoding of low imagery words in man. Life Sci. 1978;22:1555-1560.
26. Ladd SL, Sommer SA, LaBerge S, et al. Effect of phosphatidylcholine on explicit memory. Clin Neuropharmacol. 1993;16:540-549.
27. Deuster PA, Singh A, Coll R, et al. Choline ingestion does not modify physical or cognitive performance. Mil Med. 2002;167:1020-1025.
28. Harris CM, Dysken MW, Fovall P, et al. Effect of lecithin on memory in normal adults. Am J Psychiatry. 1983;140:1010-1012.
29. Benton D, Donohoe RT. The influence on cognition of the interactions between lecithin, carnitine and carbohydrate. Psychopharmacology (Berl). 2004;175:84-91.
30. Davis KL, Mohs RC, Tinklenberg JR, et al. Cholinomimetics and memory. The effect of choline chloride. Arch Neurol. 1980;37:49-52.
31. Mohs RC, Davis KL, Tinklenberg JR, et al. Choline chloride effects on memory in the elderly. Neurobiol Aging. 1980;1:21-25.
32. Sorgatz H. The effect of lecithin on the state of health and concentration in healthy adults. Fortschr Med. 1988;106:233-236.
33. Drachman DA, Glosser G, Fleming P, et al. Memory decline in the aged: treatment with lecithin and physostigmine. Neurology. 1982;32:944-950.
34. Spiers PA, Myers D, Hochanadel GS, et al. Citicoline improves verbal memory in aging. Arch Neurol. 1996;53:441-448.
35. Mapstone M, Cheema AK, Fiandaca MS, et al. Plasma phospholipids identify antecedent memory impairment in older adults. Nat Med. 2014;20:415-418.
36. Jiang X, Bar HY, Yan J, et al. A higher maternal choline intake among third-trimester pregnant women lowers placental and circulating concentrations of the antiangiogenic factor fms-like tyrosine kinase-1 (sFLT1). FASEB J. 2013;27:1245- 1253.
37. Hogeveen M, Den Heijer M, Semmekrot BA, et al. Umbilical choline and related methylamines betaine and dimethylglycine in relation to birth weight. Pediatr Res. 2013;73:783-787.
38. Ivorra C, Garcia-Vicent C, Chaves FJ, et al. Metabolomic profiling in blood from umbilical cords of low birth weight newborns. J. Transl. Med. 2012;10:142. doi:10.1186/1479-5876-10-142.
39. Sanz-Cortés M, Carbajo RJ, Crispi F, et al. Metabolomic profile of umbilical cord blood plasma from early and late intrauterine growth restricted (IUGR) neonates with and without signs of brain vasodilation. PLoS ONE. 2013;8. doi:10.1371/ journal.pone.0080121.
40. Buchman AL, Sohel M, Moukarzel A, et al. Plasma choline in normal newborns, infants, toddlers, and in very-low-birth-weight neonates requiring total parenteral nutrition. Nutrition. 2001;17:18-21.
41. Kupke IR, Heller B, Weiss P. Early indicators for the risk of atherogenesis. A field test of a new methodology on kindergarten children in Dusseldorf. Atherosclerosis. 1983;48:29-48.
42. Killgore WDS, Ross AJ, Kamiya T, et al. Citicoline affects appetite and cortico-limbic responses to images of high-calorie foods. Int J Eating Disord. 2010;43:6-13.
43. Schriewer H, Schulte H, Assmann G. HDL phosphatidyl choline and risk-factors of coronary heart disease. J Clin Chem Clin Biochem. 1984;22:515-521.
44. Yan J, Winter LB, Burns-Whitmore B, et al. Plasma choline metabolites associate with metabolic stress among young overweight men in a genotype-specific manner. Nutr Diabetes. 2012;2:e49. doi:10.1038/nutd.2012.23.
45. Floegel A, Stefan N, Yu Z, et al. Identification of serum metabolites associated with risk of type 2 diabetes using a targeted metabolomic approach. Diabetes. 2012.
46. Meikle PJ, Wong G, Barlow CK, et al. Plasma lipid profiling shows similar associations with prediabetes and type 2 diabetes. PLoS ONE. 2013;8:e74341. doi:10.1371/journal.pone.0074341.
47. Ferrannini E, Natali A, Camastra S, et al. Early metabolic markers of the development of dysglycemia and type 2 diabetes and their physiological significance. Diabetes. 2013;62:1730-1737.
48. Chen L, Chen YM, Wang LJ, et al. Higher homocysteine and lower betaine increase the risk of microangiopathy in patients with diabetes mellitus carrying the GG genotype of PEMT G774C. Diabetes Metab Res Rev. 2013;29:607-617.
49. Simonsson P, Nilsson A, Akesson B. Postprandial effects of dietary phosphatidylcholine on plasma lipoproteins in man. Am J Clin Nutr. 1982;35:36-41.
50. Wallace JMW, McCormack JM, McNulty H, et al. Choline supplementation and measures of choline and betaine status: a randomised, controlled trial in postmenopausal women. Br J Nutr. 2012;108:1264-1271.
51. Zeisel SH, Dacosta KA, Franklin PD, et al. Choline, an essential nutrient for humans. FASEB J. 1991;5:2093-2098.
52. Evans M, Njike VY, Hoxley M, et al. Effect of soy isoflavone protein and soy lecithin on endothelial function in healthy postmenopausal women. Menopause. 2007;14: 141-149.
53. Veenema K, Solis C, Li R, et al. AdequateiIntake levels of choline are sufficient for preventing elevations in serum markers of liver dysfunction in Mexican American men but are not optimal for minimizing plasma total homocysteine increases after a methionine load. Am J Clin Nutr. 2008;88:685-692.
54. Detopoulou P, Panagiotakos DB, Antonopoulou S, et al. Dietary choline and betaine intakes in relation to concentrations of inflammatory markers in healthy adults: the ATTICA study. Am J Clin Nutr. 2008;87:424-430.
55. Kalhan SC, Guo L, Edmison J, et al. Plasma metabolomic profile in nonalcoholic fatty liver disease. Metabolism. 2011;60:404-413.
56. Imajo K, Fujita K, Yoneda M, et al. Plasma free choline is a novel non-invasive biomarker for early-stage non-alcoholic steatohepatitis: a multi-center validation study. Hepatol Res. 2012;42:757-766.
57. Shaw GM, Yang W, Carmichael SL, et al. One-carbon metabolite levels in midpregnancy and risks of conotruncal heart defects. Birth Defects Res Part A Clin Mol Teratol. 2014;100:107-115.
58. Bertoia ML, Pai JK, Cooke JP, et al. Plasma homocysteine, dietary B vitamins, betaine, and choline and risk of peripheral artery disease. Atherosclerosis. 2014;235: 94-101.
59. Bidulescu A, Chambless LE, Siega-Riz AM, et al. Usual choline and betaine dietary intake and incident coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study. BMC Cardiovasc Disord. 2007;7. doi:10.1186/1471- 2261-7-20.
60. Stegemann C, Pechlaner R, Willeit P, et al. Lipidomics profiling and risk of cardiovascular disease in the prospective population-based Bruneck Study. Circulation. 2014;129:1821-1831.
61. Ried JS, Baurecht H, Stuckler F, et al. Integrative genetic and metabolite profiling analysis suggests altered phosphatidylcholine metabolism in asthma. Allergy. 2013;68:629-636.
62. Zeisel SH, Mar MH, Howe JC, et al. Concentrations of choline-containing compounds and betaine in common foods. J Nutr. 2003;133:1302-1307.
63. Fischer LM, daCosta KA, Kwock L, et al. Sex and menopausal status influence human dietary requirements for the nutrient choline. Am J Clin Nutr. 2007;85:1275- 1285.
64. Fischer LM, da Costa KA, Kwock L, et al. Dietary choline requirements of women: effects of estrogen and genetic variation. Am J Clin Nutr. 2010;92:1113-1119.
65. Holmes-McNary MQ, Cheng WL, Mar MH, et al. Choline and choline esters in human and rat milk and in infant formulas. Am J Clin Nutr. 1996;64:572-576.
66. Brion MJ, Lawlor DA, Matijasevich A, et al. What are the causal effects of breastfeeding on IQ, obesity and blood pressure? Evidence from comparing highincome with middle-income cohorts. Int J Epidemiol. 2011;40:670-680.
67. Van den Veyver IB. Genetic effects of methylation diets. Annu Rev Nutr. 2002;22: 255-282.
68. Shaw GM, Carmichael SL, Laurent C, et al. Maternal nutrient intakes and risk of orofacial clefts. Epidemiology. 2006;17:285-291.
69. Shaw GM, Vollset SE, Carmichael SL, et al. Nested case-control study of one-carbon metabolites in mid-pregnancy and risks of cleft lip with and without cleft palate. Pediatr Res. 2009;66:501-506.
70. Higgins JP, Flicker L. Lecithin for dementia and cognitive impairment. Cochrane Database Syst Rev. 2003(3):CD001015. doi:10.1002/14651858.CD001015.
71. Body R, Griffith CA, Keevil B, et al. Choline for diagnosis and prognostication of acute coronary syndromes in the emergency department. Clin Chim Acta. 2009; 404:89-94.
72. Cavusoglu E, Chhabra S, Jiang XC, et al. Relation of baseline plasma phospholipid levels to cardiovascular outcomes at two years in men with acute coronary syndrome referred for coronary angiography. Am J Cardiol. 2007;100:1739- 1743.
73. Danne O, Mockel M, Lueders C, et al. Prognostic implications of elevated whole blood choline levels in acute coronary syndromes. Am J Cardiol. 2003;91:1060- 1067.
74. Senturk T, Tutuncu A, Ozdemir B, et al. Serum choline levels in patients with stable angina and acute coronary syndromes: relation to the severity of coronary artery disease. Coron Artery Dis. 2010;21:466-471.
75. Kirsch R, Clarkson V, Shephard EG, et al. Rodent nutritional model of non-alcoholic steatohepatitis: species, strain and sex difference studies. J Gastroenterol Hepatol. 2003;18:1272-1282.
76. Buchman AL, Ament ME, Sohel M, et al. Choline deficiency causes reversible hepatic abnormalities in patients receiving parenteral nutrition: proof of a human choline requirement: a placebo-controlled trial. J Parenter Enteral Nutr. 2001;25:260-268.
77. Song J, da Costa KA, Fischer LM, et al. Polymorphism of the PEMT gene and susceptibility to nonalcoholic fatty liver disease (NAFLD). FASEB J. 2005;19:1266- 1271.
78. Clarke R, Bennett DA, Parish S, et al. Homocysteine and coronary heart disease: meta-analysis of MTHFR case-control studies, avoiding publication bias. PLoS Med. 2012;9:e1001177.
79. Meigs JB, Jacques PF, Selhub J, et al. Fasting plasma homocysteine levels in the insulin resistance syndrome: the Framingham Offspring Study. Diabetes Care. 2001; 24:1403-1410.
80. Hajer GR, van der Graaf Y, et al. Levels of homocysteine are increased in metabolic syndrome patients but are not associated with an increased cardiovascular risk, in contrast to patients without the metabolic syndrome. Heart. 2007;93:216-220.
81. Wang Z, Klipfell E, Bennett BJ, et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature. 2011;472:57-63.
82. Tang WH, Wang Z, Levison BS, et al. Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. N Engl J Med. 2013;368:1575-1584.
83. Sparks JD, Collins HL, Chirieac DV, et al. Hepatic very-low-density lipoprotein and apolipoprotein B production are increased following in vivo induction of betainehomocysteine S-methyltransferase. Biochem J. 2006;395:363-371.